CRISPR Therapeutics AG - NAMEN AKT (CRSP)

Q3 2018 Portfolio Holders as of 9/30/2018

Type / Class
Equity / NAMEN AKT
Number of holders
171
Total Shares
22.8 M
Shares change
+4.34 M
Total reported value, excl. options
$1.01 B
Value change
+$171 M
Put/Call ratio
2.53
Number of buys
87
Number of sells
-76
Price
$44.35
CUSIP
H17182108
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.